Show items per page
Elements: 10
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus Mrowietz, U; Barker, J; Boehncke, Wolf-Henning; Iversen, L; ... Warren, R B 2018
add to browser selection
Indications off-label des traitements biologiques en dermatologie Cortes Sanchez, Begonia; Laffitte, Emmanuel Alexis 2016
add to browser selection
Granulomatoses cutanées Cortes Sanchez, Begonia; Laffitte, Emmanuel Alexis 2016
add to browser selection
Indications off-label des traitements biologiques en dermatologie Cortes Sanchez, Begonia; Laffitte, Emmanuel Alexis 2016
add to browser selection
The psoriasis xenograft SCID mouse model : a tool in translational research Boehncke, Wolf-Henning 2012
add to browser selection
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) Saurat, Jean-Hilaire; Stingl, G.; Dubertret, L.; Papp, K.; ... Camez, A. 2008
add to browser selection
Infliximab then efalizumab, the 'hit and run' approach does not work Barde, Caroline; Thielen, A M.; Saurat, Jean-Hilaire 2008
add to browser selection
Safety and efficacy of alefacept in elderly patients and other special populations Gottlieb, Alice B.; Boehncke, Wolf-Henning; Darif, Mohamed 2005
add to browser selection
Proteasome inhibition: a new anti-inflammatory strategy Elliott, Peter J.; Zollner, Thomas Matthias; Boehncke, Wolf-Henning 2003
add to browser selection
Delayed-type reactivity to calcipotriol without cross-sensitization to tacalcitol Zollner, Thomas Matthias; Ochsendorf, Falk Rudiger; Hensel, O.; Thaci, Diamant; ... Kaufmann, Roland 1997